Hadas Reuveni
Direttore Tecnico/Scientifico/R&S presso PURPLE BIOTECH LTD
Posizioni attive di Hadas Reuveni
Società | Posizione | Inizio | Fine |
---|---|---|---|
PURPLE BIOTECH LTD | Direttore Tecnico/Scientifico/R&S | 01/01/2017 | - |
Tyrnovo Ltd.
Tyrnovo Ltd. Drugstore ChainsRetail Trade Tyrnovo Ltd. operates as a pharmaceutical company. It develops drugs that eliminates a key protein in cancer, resulting in improved cancer therapy, prevention of drug resistance, and increased life expectancy. The company was founded by Hadas Reuveni and is headquartered in Herzliya, Israel. | Amministratore Delegato | - | - |
Fondatore | - | - |
Storia della carriera di Hadas Reuveni
Precedenti posizioni note di Hadas Reuveni
Società | Posizione | Inizio | Fine |
---|---|---|---|
NovoTyr Therapeutics Ltd.
NovoTyr Therapeutics Ltd. Medical SpecialtiesHealth Technology NovoTyr Therapeutics Ltd. develops insulin-like growth factor receptor inhibitors. It provides services in the biotechnology, drug development, cancer and other proliferative disease sectors. The company was founded by Alexander Levitzki in 2005 and is headquartered in Kiryat Shmona, Israel | Amministratore Delegato | 01/01/2005 | 01/01/2012 |
KERYX BIOPHARMACEUTICALS | Direttore Tecnico/Scientifico/R&S | 01/01/2001 | 01/01/2004 |
AngioB Ltd.
AngioB Ltd. Medical SpecialtiesHealth Technology AngioB Ltd. developed treatments for ischemic heart conditions. It also developed proprietary novel pro-angiogenic drugs to treat cardiovascular diseases and peripheral ischemic disorders. The company started in-vivo experiments to evaluate the pro-angiogenic potential of its lead compound in clinical-relevant models. AngioB was founded in July 2006 and was headquartered in Kiryat Shmona, Israel | Direttore/Membro del Consiglio | 01/07/2006 | - |
Direttore Tecnico/Scientifico/R&S | 01/07/2006 | - | |
Fondatore | 01/06/2010 | - |
Formazione di Hadas Reuveni
The Hebrew University of Jerusalem | Doctorate Degree |
Statistiche
Distribuzione geografica
Israele | 6 |
Stati Uniti | 2 |
Posizioni
Chief Tech/Sci/R&D Officer | 3 |
Founder | 2 |
Chief Executive Officer | 2 |
Settori
Health Technology | 5 |
Consumer Services | 2 |
Retail Trade | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
PURPLE BIOTECH LTD | Health Technology |
Aziende private | 4 |
---|---|
Keryx Biopharmaceuticals, Inc.
Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA. | Health Technology |
AngioB Ltd.
AngioB Ltd. Medical SpecialtiesHealth Technology AngioB Ltd. developed treatments for ischemic heart conditions. It also developed proprietary novel pro-angiogenic drugs to treat cardiovascular diseases and peripheral ischemic disorders. The company started in-vivo experiments to evaluate the pro-angiogenic potential of its lead compound in clinical-relevant models. AngioB was founded in July 2006 and was headquartered in Kiryat Shmona, Israel | Health Technology |
NovoTyr Therapeutics Ltd.
NovoTyr Therapeutics Ltd. Medical SpecialtiesHealth Technology NovoTyr Therapeutics Ltd. develops insulin-like growth factor receptor inhibitors. It provides services in the biotechnology, drug development, cancer and other proliferative disease sectors. The company was founded by Alexander Levitzki in 2005 and is headquartered in Kiryat Shmona, Israel | Health Technology |
Tyrnovo Ltd.
Tyrnovo Ltd. Drugstore ChainsRetail Trade Tyrnovo Ltd. operates as a pharmaceutical company. It develops drugs that eliminates a key protein in cancer, resulting in improved cancer therapy, prevention of drug resistance, and increased life expectancy. The company was founded by Hadas Reuveni and is headquartered in Herzliya, Israel. | Retail Trade |
- Borsa valori
- Insiders
- Hadas Reuveni
- Esperienza